Immune-complexes solubilization: Effect of antigen-antibody ratio and relative role of alternative and classical complement pathways
- 1 October 1983
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 20 (10) , 1069-1072
- https://doi.org/10.1016/0161-5890(83)90114-1
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- A one-step procedure for preparation of classical pathway (C1q) and alternative pathway (factor D) depleted human serumJournal of Immunological Methods, 1982
- Decreased capacity to solubilize immune complexes in sera from patients with systemic lupus erythematosusArthritis & Rheumatism, 1981
- Deficiency of c7 with systemic lupus erythematosus. solubilization of immune complexes in complement‐deficient seraArthritis & Rheumatism, 1981
- Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway.Journal of Clinical Investigation, 1978
- Evidences proving the intercalation hypothesis of the C-mediated complex release activity (CRA)Immunochemistry, 1978
- Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.The Journal of Experimental Medicine, 1977
- Studies on the mechanism of solubilization of immune precipitates by serum.The Journal of Experimental Medicine, 1976
- Activation of the Alternate Pathway of Human Complement by Rabbit CellsThe Journal of Immunology, 1974
- THE ANTIGENIC AND MOLECULAR ALTERATIONS OF C3 IN THE FLUID PHASE DURING AN IMMUNE REACTION IN NORMAL HUMAN SERUMThe Journal of Experimental Medicine, 1971
- Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific ActivityNature, 1962